NEW YORK (GenomeWeb) – Turmoil. Disappointment. Anxiety. Uncertainty. These are the words that some British researchers used to describe the state of genomics in the UK following the country's referendum to leave the European Union nearly one month ago.
Interviews conducted with leading UK researchers in recent weeks about the so-called Brexit revealed apprehension about losing access to European funding, limitations on freedom of movement, and a potential exodus of biotechnology companies to the EU.